Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) was the recipient of some unusual options trading activity on Wednesday. Investors acquired 1,002 put options on the stock. This represents an increase of approximately 1,791% compared to the average volume of 53 put options.

Insider Activity

In other Maravai LifeSciences news, insider Carl Hull purchased 175,000 shares of Maravai LifeSciences stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average price of $5.64 per share, with a total value of $987,000.00. Following the transaction, the insider now owns 175,000 shares in the company, valued at $987,000. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.63% of the company’s stock.

Institutional Trading of Maravai LifeSciences

Hedge funds have recently added to or reduced their stakes in the stock. Point72 Asia Singapore Pte. Ltd. bought a new stake in Maravai LifeSciences in the second quarter worth about $32,000. Venturi Wealth Management LLC bought a new stake in Maravai LifeSciences in the third quarter worth about $47,000. Custom Index Systems LLC bought a new stake in Maravai LifeSciences in the third quarter worth about $97,000. Y Intercept Hong Kong Ltd purchased a new position in shares of Maravai LifeSciences in the third quarter worth about $105,000. Finally, Headlands Technologies LLC increased its stake in shares of Maravai LifeSciences by 205.9% in the second quarter. Headlands Technologies LLC now owns 14,935 shares of the company’s stock worth $107,000 after purchasing an additional 10,053 shares in the last quarter. Institutional investors own 50.25% of the company’s stock.

Maravai LifeSciences Stock Up 1.3 %

MRVI opened at $6.13 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 10.74 and a quick ratio of 9.94. The company’s 50-day moving average is $5.70 and its 200 day moving average is $7.42. Maravai LifeSciences has a fifty-two week low of $4.28 and a fifty-two week high of $11.56. The firm has a market capitalization of $1.55 billion, a P/E ratio of -3.74 and a beta of -0.07.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on MRVI shares. Robert W. Baird decreased their target price on shares of Maravai LifeSciences from $10.00 to $9.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Royal Bank of Canada decreased their price objective on Maravai LifeSciences from $17.00 to $13.00 and set an “outperform” rating for the company in a report on Friday, November 8th. William Blair restated a “market perform” rating on shares of Maravai LifeSciences in a report on Friday, November 8th. Guggenheim initiated coverage on Maravai LifeSciences in a report on Thursday, December 19th. They set a “neutral” rating for the company. Finally, The Goldman Sachs Group cut Maravai LifeSciences from a “neutral” rating to a “sell” rating and dropped their price objective for the company from $7.00 to $4.25 in a research note on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Maravai LifeSciences has a consensus rating of “Hold” and an average target price of $10.28.

Maravai LifeSciences Company Profile

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.